标题
Antibiotic therapy and outcome from immune-checkpoint inhibitors
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-07
DOI
10.1186/s40425-019-0775-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of prior antibiotic use on the efficacy of nivolumab for non‑small cell lung cancer
- (2019) Taiki Hakozaki et al. Oncology Letters
- A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
- (2019) Alessio Cortellini et al. Journal for ImmunoTherapy of Cancer
- Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
- (2019) Arielle Elkrief et al. OncoImmunology
- Impact of antibiotic use on response to treatment with immune checkpoint inhibitors.
- (2019) Uqba Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
- (2019) Rossella Cianci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
- (2019) Sha Zhao et al. LUNG CANCER
- Metabolism at the centre of the host–microbe relationship
- (2019) K. M. Maslowski CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer
- (2019) Giulia Galli et al. LUNG CANCER
- Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
- (2019) Clara Depommier et al. NATURE MEDICINE
- Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
- (2019) Julia Ouaknine Krief et al. Journal for ImmunoTherapy of Cancer
- The prognostic role of obesity is independent of sex in cancer patients treated with immune checkpoint inhibitors: A pooled analysis of 4090 cancer patients
- (2019) Huilin Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario
- (2019) Giovanni Rossi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- Antibiotic use and outcomes with systemic therapy in metastatic renal cell carcinoma (mRCC).
- (2018) Aly-Khan A. Lalani et al. JOURNAL OF CLINICAL ONCOLOGY
- The gut microbiota influences anticancer immunosurveillance and general health
- (2018) Bertrand Routy et al. Nature Reviews Clinical Oncology
- Disruption of the Gut Ecosystem by Antibiotics
- (2018) Mi Young Yoon et al. YONSEI MEDICAL JOURNAL
- Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
- (2018) Florian Huemer et al. Oncotarget
- Cumulative antibiotic use and efficacy of immune checkpoint inhibitors in patients with advanced cancer.
- (2018) Nadina Tinsley et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibiotic use and overall survival in lung cancer patients receiving nivolumab.
- (2018) Tien Phuc Do et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors
- (2018) Jibran Ahmed et al. OncoImmunology
- Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
- (2017) Lisa Derosa et al. JOURNAL OF CLINICAL ONCOLOGY
- P1.07-008 Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors
- (2017) J. Thompson et al. Journal of Thoracic Oncology
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Cancer and the gut microbiota: An unexpected link
- (2015) Laurence Zitvogel et al. Science Translational Medicine
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Antibiotics, microbiota, and immune defense
- (2012) Carles Ubeda et al. TRENDS IN IMMUNOLOGY
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
- (2010) L. Dethlefsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started